Clinical trials
Phase 3 Obesity trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 4 |
| 2025 | 13 |
| 2026 | 18 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
| Completed | 19 |
| Active, not recruiting | 13 |
| Not yet recruiting | 3 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 21 |
| Novo Nordisk A/S | 14 |
| Amgen | 8 |
| Boehringer Ingelheim | 4 |
| AstraZeneca | 3 |
| Pfizer | 3 |
| Sanofi | 3 |
| Hoffmann-La Roche | 2 |
| Eisai Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 59 |
| Overweight | 43 |
| Diabetes Mellitus, Type 2 | 14 |
| Nutrition Disorders | 7 |
| Sleep Apnea, Obstructive | 5 |
| Diabetes Mellitus | 3 |
| Body Weight | 2 |
| Heart Failure | 2 |
| Osteoarthritis | 2 |
| Overnutrition | 2 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.